Rainbow Childrens Medicare Ltd
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]
- Market Cap ₹ 14,806 Cr.
- Current Price ₹ 1,458
- High / Low ₹ 1,625 / 1,009
- Stock P/E 59.8
- Book Value ₹ 162
- Dividend Yield 0.24 %
- ROCE 17.4 %
- ROE 15.9 %
- Face Value ₹ 10.0
Pros
- Company's median sales growth is 22.8% of last 10 years
Cons
- Stock is trading at 8.98 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE 250 SmallCap Index BSE 400 MidSmallCap Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 169 | 234 | 321 | 402 | 543 | 719 | 650 | 974 | 1,174 | 1,297 | 1,516 | 1,703 | |
| 128 | 204 | 266 | 332 | 391 | 519 | 485 | 666 | 774 | 865 | 1,022 | 1,155 | |
| Operating Profit | 41 | 30 | 55 | 69 | 151 | 201 | 165 | 308 | 400 | 432 | 494 | 548 |
| OPM % | 24% | 13% | 17% | 17% | 28% | 28% | 25% | 32% | 34% | 33% | 33% | 32% |
| 10 | 16 | 11 | 10 | 8 | 10 | 10 | 19 | 31 | 37 | 51 | 42 | |
| Interest | 3 | 3 | 3 | 4 | 42 | 48 | 46 | 56 | 58 | 63 | 77 | 82 |
| Depreciation | 9 | 18 | 22 | 28 | 60 | 69 | 73 | 83 | 90 | 112 | 138 | 151 |
| Profit before tax | 38 | 24 | 41 | 47 | 58 | 93 | 56 | 187 | 282 | 295 | 330 | 358 |
| Tax % | 35% | 28% | 24% | 22% | 22% | 41% | 29% | 26% | 25% | 26% | 26% | 21% |
| 25 | 17 | 31 | 36 | 45 | 55 | 40 | 139 | 212 | 218 | 244 | 282 | |
| EPS in Rs | 26.74 | 18.22 | 33.78 | 8.25 | 10.14 | 12.68 | 9.10 | 14.70 | 20.77 | 21.38 | 23.97 | 27.40 |
| Dividend Payout % | 7% | 11% | 7% | 12% | 10% | 16% | 0% | 14% | 14% | 14% | 13% | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 21% |
| 3 Years: | 13% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 44% |
| 3 Years: | 6% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 19% |
| 3 Years: | 17% |
| Last Year: | 16% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 44 | 44 | 44 | 44 | 94 | 102 | 102 | 102 | 102 |
| Reserves | 166 | 275 | 308 | 307 | 317 | 350 | 391 | 498 | 958 | 1,157 | 1,367 | 1,547 |
| 22 | 24 | 26 | 24 | 476 | 501 | 529 | 592 | 570 | 765 | 764 | 891 | |
| 34 | 41 | 55 | 73 | 89 | 123 | 116 | 112 | 140 | 146 | 145 | 236 | |
| Total Liabilities | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,771 | 2,170 | 2,377 | 2,775 |
| 78 | 123 | 174 | 296 | 702 | 702 | 772 | 858 | 931 | 1,253 | 1,398 | 1,756 | |
| CWIP | 35 | 31 | 7 | 12 | 23 | 43 | 29 | 6 | 23 | 20 | 28 | 79 |
| Investments | 7 | 2 | 6 | 0 | 3 | 10 | 18 | 22 | 58 | 308 | 571 | 404 |
| 111 | 194 | 212 | 140 | 199 | 265 | 262 | 409 | 759 | 590 | 380 | 535 | |
| Total Assets | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,771 | 2,170 | 2,377 | 2,775 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 17 | 36 | 48 | 127 | 170 | 143 | 224 | 329 | 321 | 396 | 420 | |
| -20 | -107 | -33 | -42 | -117 | -117 | -83 | -175 | -465 | -226 | -268 | -259 | |
| -7 | 93 | -1 | -7 | -9 | -52 | -61 | -44 | 143 | -102 | -118 | -147 | |
| Net Cash Flow | -1 | 3 | 1 | -2 | 2 | 2 | -1 | 4 | 7 | -7 | 10 | 14 |
| Free Cash Flow | -35 | -46 | -21 | -103 | 42 | 96 | 67 | 162 | 188 | -32 | 250 | 204 |
| CFO/OP | 95% | 88% | 79% | 88% | 94% | 95% | 102% | 93% | 103% | 95% | 97% | 95% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 10 | 16 | 14 | 24 | 22 | 25 | 15 | 16 | 20 | 19 | 22 |
| Inventory Days | 39 | 35 | 48 | 36 | 32 | 55 | 36 | 28 | 43 | 53 | 52 | 67 |
| Days Payable | 121 | 107 | 142 | 151 | 197 | 202 | 190 | 121 | 182 | 180 | 170 | 162 |
| Cash Conversion Cycle | -72 | -62 | -79 | -100 | -141 | -124 | -130 | -78 | -123 | -107 | -100 | -73 |
| Working Capital Days | -35 | -36 | -28 | -31 | -26 | -18 | -17 | -16 | 73 | 43 | 19 | 8 |
| ROCE % | 22% | 11% | 14% | 14% | 16% | 16% | 11% | 23% | 24% | 19% | 19% | 17% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| ALOS days |
|
||||||
| ARPOB INR per day |
|||||||
| Capacity Beds count |
|||||||
| IP Discharges count |
|||||||
| Occupancy % |
|||||||
| OP Consultations count |
|||||||
| Deliveries count |
|||||||
| Number of Hospitals count |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - Earnings Conference Call for discussion on financial results declared for quarter ended June 30, 2026
-
ESG Rating From CRISIL ESG Rating & Analytics Limited
2d - CRISIL ESG assigned Rainbow a 61 ESG rating and 73 core rating for FY2025-26, improving to Strong.
-
Board Meeting Intimation for Declaring Unaudited Financial Results (Standalone & Consolidated) For Quarter Ended June 30, 2026 And Other Matters
22 Jul - Board meets July 30, 2026 to approve Q1 FY27 standalone and consolidated results; trading window closed.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Jul
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Jul - Intimation for Newspaper Publication for dispatch of Notice of 28th Annual General Meeting and Integrated Annual report for the Financial year 2025-26.
Annual reports
Concalls
-
Jun 2026Transcript PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptAI SummaryPPT
-
Jun 2022Transcript PPT
Business Overview[1]
The company operates 22 hospitals and 5 clinics across 9 cities, with a total bed capacity of 2,285. It specializes in pediatric healthcare under "Rainbow Children's Hospital" and women's healthcare under "Birthright by Rainbow."